NCT00816257

Brief Summary

All patients enrolled in the registry will be recipients of single and double lung transplantation (bilateral sequential, heart-lung, or living related donor grafts). During the routine management of lung recipients frequent surveillance of the lung allograft is necessary. This routinely involves: measurement of pulmonary functions, chest radiography, collection of peripheral blood to assess other organ function and monitor therapeutic drug levels, and bronchoscopic evaluation allowing for collection of lung lavage fluid and lung tissue biopsy. This surveillance normally follows a set schedule during the first one to two years following the transplant procedure. Surveillance is routinely performed at weeks 2, 8, 12, 24, 36, and 52 during the first year following the transplant procedure. Additional surveillance may be performed at any time when clinically indicated for the optimal management of the recipient. Information and specimens collected from each of these encounters will be entered in the data registry and specimen repository.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2005

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2005

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

December 31, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 1, 2009

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

November 20, 2013

Status Verified

November 1, 2013

Enrollment Period

8 years

First QC Date

December 31, 2008

Last Update Submit

November 18, 2013

Conditions

Keywords

lung tissue repository

Outcome Measures

Primary Outcomes (1)

  • data registry and lung tissue repository

    ongoing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

lung transplant recipients

You may qualify if:

  • recipients of single and double lung transplantation (bilateral sequential, heart-lung, or living related donor grafts).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43210, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

BAL specimen blood lung biopsy specimens

Study Officials

  • David Nunley, MD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Karen Wood M.D.

Study Record Dates

First Submitted

December 31, 2008

First Posted

January 1, 2009

Study Start

November 1, 2005

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

November 20, 2013

Record last verified: 2013-11

Locations